Overall market sentiment has been high on DarioHealth Corp (DRIO) stock lately. DRIO receives a Bullish rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With DRIO Stock Today?
DarioHealth Corp (DRIO) stock is trading at $16.78 as of 10:22 AM on Thursday, May 20, an increase of $1.18, or 7.56% from the previous closing price of $15.60. The stock has traded between $15.62 and $16.79 so far today. Volume today is less active than usual. So far 61,796 shares have traded compared to average volume of 213,091 shares.
To screen for more stocks like DarioHealth Corp click here.
More About DarioHealth Corp
DarioHealth Corp is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue by sales of its product.
Click Here to get the full Stock Score Report on DarioHealth Corp (DRIO) Stock.
